Veracyte, Inc. (VCYT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 20.75 |
| Open | 21.10 |
| Bid | 21.11 x 200 |
| Ask | 21.20 x 100 |
| Day's range | 20.82 - 21.61 |
| 52-week range | 18.61 - 30.52 |
| Volume | |
| Avg. volume | 705,812 |
| Market cap | 1.617B |
| Beta (5Y monthly) | 1.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.93 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 29.83 |
Business WireVeracyte Announces that New Afirma GRID Data Suggest Prognostic Ability of Molecular Testing for Thyroid Tumors
SOUTH SAN FRANCISCO, Calif., June 03, 2024--Veracyte Announces that New Afirma GRID Data Suggest Prognostic Ability of Molecular Testing for Thyroid Tumors.
ZacksWall Street Analysts Think Veracyte (VCYT) Could Surge 39.07%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 39.1% in Veracyte (VCYT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
ZacksVeracyte (VCYT) Crossed Above the 50-Day Moving Average: What That Means for Investors
Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?
© 2024 Yahoo. All rights reserved.